Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	Fc-gamma receptor I complex binding	IGHG1 IGHG2 IGHG3 IGHG4	2.96e-07	7	194	4	GO:0034988
GeneOntologyMolecularFunction	immunoglobulin receptor binding	IGHG1 IGHG2 IGHG3 IGHG4	4.54e-05	21	194	4	GO:0034987
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	GBF1 TRIO MYCBP2 BCR ALS2CL PLEKHG1 PLEKHG4 ARFGEF1 ARHGEF18 RASGRP1	9.10e-05	231	194	10	GO:0005085
GeneOntologyMolecularFunction	structural constituent of postsynaptic density	DLG2 DLG3 SHANK2	1.41e-04	11	194	3	GO:0098919
GeneOntologyMolecularFunction	structural constituent of postsynaptic specialization	DLG2 DLG3 SHANK2	2.40e-04	13	194	3	GO:0098879
GeneOntologyMolecularFunction	nuclease activity	PNKP ENPP2 XRN1 DCLRE1A SETMAR ASTE1 FAN1 HELZ2 PRORP	4.44e-04	231	194	9	GO:0004518
GeneOntologyBiologicalProcess	positive regulation of acute inflammatory response to antigenic stimulus	CNR1 IGHG1 IGHG2 IGHG3 IGHG4	4.15e-07	17	196	5	GO:0002866
GeneOntologyBiologicalProcess	positive regulation of type I hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	5.37e-07	8	196	4	GO:0001812
GeneOntologyBiologicalProcess	regulation of type I hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	9.60e-07	9	196	4	GO:0001810
GeneOntologyBiologicalProcess	positive regulation of type IIa hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	1.59e-06	10	196	4	GO:0001798
GeneOntologyBiologicalProcess	type I hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	1.59e-06	10	196	4	GO:0016068
GeneOntologyBiologicalProcess	positive regulation of type II hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	1.59e-06	10	196	4	GO:0002894
GeneOntologyBiologicalProcess	positive regulation of inflammatory response to antigenic stimulus	CNR1 IGHG1 IGHG2 IGHG3 IGHG4	2.16e-06	23	196	5	GO:0002863
GeneOntologyBiologicalProcess	regulation of type IIa hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	2.48e-06	11	196	4	GO:0001796
GeneOntologyBiologicalProcess	regulation of type II hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	2.48e-06	11	196	4	GO:0002892
GeneOntologyBiologicalProcess	regulation of acute inflammatory response to antigenic stimulus	CNR1 IGHG1 IGHG2 IGHG3 IGHG4	5.01e-06	27	196	5	GO:0002864
GeneOntologyBiologicalProcess	antibody-dependent cellular cytotoxicity	IGHG1 IGHG2 IGHG3 IGHG4	5.29e-06	13	196	4	GO:0001788
GeneOntologyBiologicalProcess	type IIa hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	9.94e-06	15	196	4	GO:0001794
GeneOntologyBiologicalProcess	positive regulation of hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	9.94e-06	15	196	4	GO:0002885
GeneOntologyBiologicalProcess	type II hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	9.94e-06	15	196	4	GO:0002445
GeneOntologyBiologicalProcess	regulation of hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	2.74e-05	19	196	4	GO:0002883
GeneOntologyBiologicalProcess	positive regulation of acute inflammatory response	CNR1 IGHG1 IGHG2 IGHG3 IGHG4	4.71e-05	42	196	5	GO:0002675
GeneOntologyBiologicalProcess	acute inflammatory response to antigenic stimulus	CNR1 IGHG1 IGHG2 IGHG3 IGHG4	4.71e-05	42	196	5	GO:0002438
GeneOntologyBiologicalProcess	complement activation, classical pathway	IGHG1 IGHG2 IGHG3 IGHG4 MASP2	5.92e-05	44	196	5	GO:0006958
GeneOntologyBiologicalProcess	hypersensitivity	IGHG1 IGHG2 IGHG3 IGHG4	8.55e-05	25	196	4	GO:0002524
GeneOntologyBiologicalProcess	positive regulation of myeloid leukocyte mediated immunity	IGHG1 IGHG2 IGHG3 IGHG4	1.79e-04	30	196	4	GO:0002888
GeneOntologyBiologicalProcess	urea cycle	SLC25A2 SLC25A15 AGMAT	2.25e-04	13	196	3	GO:0000050
GeneOntologyBiologicalProcess	cell-cell adhesion	ABCA12 CDHR1 ADGRV1 ITGAX JAK3 CLIC1 DLG2 DLG3 YTHDF2 TNFAIP8L2 ZAN PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 L1CAM ITGA10 GPAM PTPRU RASGRP1 SIGLEC1 IL7R	2.42e-04	1077	196	23	GO:0098609
GeneOntologyBiologicalProcess	sphinganine metabolic process	DEGS2 SPTLC2	2.68e-04	3	196	2	GO:0006667
GeneOntologyBiologicalProcess	mitochondrial L-ornithine transmembrane transport	SLC25A2 SLC25A15	2.68e-04	3	196	2	GO:1990575
GeneOntologyBiologicalProcess	regulation of inflammatory response to antigenic stimulus	CNR1 IGHG1 IGHG2 IGHG3 IGHG4	2.84e-04	61	196	5	GO:0002861
GeneOntologyBiologicalProcess	humoral immune response mediated by circulating immunoglobulin	IGHG1 IGHG2 IGHG3 IGHG4 MASP2	3.07e-04	62	196	5	GO:0002455
GeneOntologyBiologicalProcess	urea metabolic process	SLC25A2 SLC25A15 AGMAT	3.53e-04	15	196	3	GO:0019627
GeneOntologyBiologicalProcess	nitrogen cycle metabolic process	SLC25A2 SLC25A15 AGMAT	3.53e-04	15	196	3	GO:0071941
GeneOntologyBiologicalProcess	regulation of acute inflammatory response	CNR1 IGHG1 IGHG2 IGHG3 IGHG4	4.41e-04	67	196	5	GO:0002673
GeneOntologyBiologicalProcess	inflammatory response to antigenic stimulus	CNR1 RASGRP1 IGHG1 IGHG2 IGHG3 IGHG4	4.54e-04	103	196	6	GO:0002437
GeneOntologyCellularComponent	IgG immunoglobulin complex	IGHG1 IGHG2 IGHG3 IGHG4	7.26e-06	14	198	4	GO:0071735
GeneOntologyCellularComponent	immunoglobulin complex, circulating	IGHG1 IGHG2 IGHG3 IGHG4	1.69e-05	17	198	4	GO:0042571
MousePheno	absent memory B cells	IGHG1 IGHG2 IGHG3 IGHG4	1.61e-08	4	159	4	MP:0008094
MousePheno	decreased memory B cell number	JAK3 IGHG1 IGHG2 IGHG3 IGHG4	2.17e-08	9	159	5	MP:0008729
MousePheno	abnormal memory B cell number	JAK3 IGHG1 IGHG2 IGHG3 IGHG4	7.82e-08	11	159	5	MP:0008093
MousePheno	abnormal memory B cell morphology	JAK3 IGHG1 IGHG2 IGHG3 IGHG4	3.29e-07	14	159	5	MP:0002440
MousePheno	decreased IgG2c level	IGHG1 IGHG2 IGHG3 IGHG4	5.00e-06	11	159	4	MP:0008897
MousePheno	abnormal plasma cell differentiation	IGHG1 IGHG2 IGHG3 IGHG4	2.00e-05	15	159	4	MP:0008099
MousePheno	enhanced humoral immune response	IGHG1 IGHG2 IGHG3 IGHG4	3.42e-05	17	159	4	MP:0020155
MousePheno	increased IgE level	JAK3 COL17A1 RASGRP1 IGHG1 IGHG2 IGHG3 IGHG4	4.34e-05	83	159	7	MP:0002497
MousePheno	abnormal IgG2c level	IGHG1 IGHG2 IGHG3 IGHG4	8.29e-05	21	159	4	MP:0020178
MousePheno	increased plasma cell number	RASGRP1 IGHG1 IGHG2 IGHG3 IGHG4	8.53e-05	40	159	5	MP:0008097
Domain	Cadherin_tail	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	3.92e-05	37	195	5	PF15974
Domain	Cadherin_CBD	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	3.92e-05	37	195	5	IPR031904
Domain	Cadherin_C	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	7.33e-05	42	195	5	IPR032455
Domain	Cadherin_C_2	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	7.33e-05	42	195	5	PF16492
Domain	-	TRIO BCR ALS2CL PLEKHG1 PLEKHG4 ARHGEF18	9.78e-05	71	195	6	1.20.900.10
Domain	DH-domain	TRIO BCR ALS2CL PLEKHG1 PLEKHG4 ARHGEF18	9.78e-05	71	195	6	IPR000219
Domain	DUF3657	FAM135A FAM135B	1.08e-04	2	195	2	IPR022122
Domain	DUF676	FAM135A FAM135B	1.08e-04	2	195	2	PF05057
Domain	DUF3657	FAM135A FAM135B	1.08e-04	2	195	2	PF12394
Domain	DUF676_lipase-like	FAM135A FAM135B	1.08e-04	2	195	2	IPR007751
Domain	Ig-like_fold	TRIO MYCBP2 IL18RAP SEMA3A PTPRB PLXNB1 HSPG2 L1CAM PTPRU SEMA4G SHANK2 TIE1 IGHG1 IGHG2 IGHG3 IGHG4 TGM7 SIGLEC1 IL7R	1.57e-04	706	195	19	IPR013783
Domain	DH_1	TRIO BCR PLEKHG1 PLEKHG4 ARHGEF18	5.07e-04	63	195	5	PS00741
Domain	Cadherin_2	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	5.86e-04	65	195	5	PF08266
Domain	Cadherin_N	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	5.86e-04	65	195	5	IPR013164
Domain	Pecanex_C	PCNX3 PCNX4	6.42e-04	4	195	2	PF05041
Domain	MAGUK_N_PEST	DLG2 DLG3	6.42e-04	4	195	2	PF10608
Domain	PDZ_assoc	DLG2 DLG3	6.42e-04	4	195	2	PF10600
Domain	DLG1_PEST_dom	DLG2 DLG3	6.42e-04	4	195	2	IPR019590
Domain	PDZ_assoc	DLG2 DLG3	6.42e-04	4	195	2	IPR019583
Domain	MAGUK_N_PEST	DLG2 DLG3	6.42e-04	4	195	2	SM01277
Domain	DLG1	DLG2 DLG3	6.42e-04	4	195	2	IPR016313
Domain	Sec7_N	GBF1 ARFGEF1	6.42e-04	4	195	2	IPR032691
Domain	Sec7_N	GBF1 ARFGEF1	6.42e-04	4	195	2	PF12783
Domain	Pecanex	PCNX3 PCNX4	6.42e-04	4	195	2	IPR007735
Domain	GDS_CDC24_CS	TRIO BCR PLEKHG1 PLEKHG4	7.12e-04	39	195	4	IPR001331
Domain	RhoGEF	TRIO BCR PLEKHG1 PLEKHG4 ARHGEF18	7.21e-04	68	195	5	SM00325
Domain	RhoGEF	TRIO BCR PLEKHG1 PLEKHG4 ARHGEF18	8.23e-04	70	195	5	PF00621
Domain	DH_2	TRIO BCR PLEKHG1 PLEKHG4 ARHGEF18	8.23e-04	70	195	5	PS50010
Domain	MFS	SPNS1 SPNS2 SLCO4A1 SLC46A1 SLC2A6 SLC22A5	9.50e-04	108	195	6	PS50850
Domain	Cadherin_CS	CDHR1 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	9.97e-04	109	195	6	IPR020894
Domain	CADHERIN_1	CDHR1 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	1.20e-03	113	195	6	PS00232
Domain	Cadherin	CDHR1 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	1.20e-03	113	195	6	PF00028
Domain	CADHERIN_2	CDHR1 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	1.26e-03	114	195	6	PS50268
Domain	-	CDHR1 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	1.26e-03	114	195	6	2.60.40.60
Domain	CA	CDHR1 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	1.32e-03	115	195	6	SM00112
Domain	PSI	SEMA3A PLXNB1 PLXDC1 SEMA4G	1.33e-03	46	195	4	SM00423
Domain	Cadherin-like	CDHR1 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	1.38e-03	116	195	6	IPR015919
Domain	Cadherin	CDHR1 PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	1.50e-03	118	195	6	IPR002126
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	GBF1 NUP85 GTPBP6 PCNX3 TRIO MYCBP2 SLCO4A1 CUL9 TMEM187 BCR TBC1D24 JAK3 PLEKHG1 ZNRF3 PCYT2 POLL ABCC10 RBM38 NPC1 HSPG2 L1CAM GRID1 CFAP43 HUWE1 SHANK2 MTHFR PCNX4 CSPG4 MARK4 HELZ2 PUM1	2.79e-13	1105	199	31	35748872
Pubmed	Sequence analysis of cloned cDNA encoding part of an immunoglobulin heavy chain.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	113776
Pubmed	Highly specific anti-estradiol antibodies: structural characterisation and binding diversity.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	11812141
Pubmed	Multiple amino acid substitutions between murine gamma 2a heavy chain Fc regions of Ig1a and Ig1b allotypic forms.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6794027
Pubmed	Further evidence that BALB/c and C57BL/6 gamma 2a genes originate from two distinct isotypes.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	2510996
Pubmed	Spontaneous deletions in Ig heavy chain genes: flanking sequences influence splice site selection.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	1754385
Pubmed	Sialic acid residues are essential for the anaphylactic activity of murine IgG1 antibodies.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	19050247
Pubmed	An autoimmune disease variant of IgG1 modulates B cell activation and differentiation.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	30287618
Pubmed	Switch transcripts in immunoglobulin class switching.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	7892607
Pubmed	Determination of the primary structure of a mouse G2a immunoglobulin. Identification of the disulfide bridges.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	4565406
Pubmed	IgG1 protects against renal disease in a mouse model of cryoglobulinaemia.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	25363774
Pubmed	Mutational deglycosylation of the Fc portion of immunoglobulin G causes O-sulfation of tyrosine adjacently preceding the originally glycosylated site.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	20621099
Pubmed	Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	12414967
Pubmed	Shutdown of class switch recombination by deletion of a switch region control element.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	8438159
Pubmed	Passive anaphylaxis in mice with gamma-G antibodies. V. Competitive effects of different immunoglobulins and inhibition of reactions with antiglobulin sera.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	4098598
Pubmed	Mouse immunoglobulin genes: a bacterial plasmid containing the entire coding sequence for a pre-gamma 2a heavy chain.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6253932
Pubmed	Immunoglobulin gamma 1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6769752
Pubmed	Mouse immunoglobulin allotypes: post-duplication divergence of gamma 2a and gamma 2b chain genes.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6803173
Pubmed	Linkage of the four gamma subclass heavy chain genes.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6264445
Pubmed	Sequences near the 3' secretion-specific polyadenylation site influence levels of secretion-specific and membrane-specific IgG2b mRNA in myeloma cells.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	2878362
Pubmed	IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	25867470
Pubmed	Sequence of the gamma 2b membrane 3' untranslated region: polya site determination and comparison to the gamma 2a membrane 3' untranslated region.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	1542303
Pubmed	Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	9725203
Pubmed	Nucleotide sequences of all the gamma gene loci of murine immunoglobulin heavy chains.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	9126488
Pubmed	The IL-4 induced increase in the frequency of resting murine splenic B cells expressing germline Ig heavy chain gamma 1 transcripts correlates with subsequent switching to IgG1.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	8452816
Pubmed	Determination of the primary structure of a mouse IgG2a immunoglobulin:amino-acid sequence of the Fc fragment. Implications for the evolution of immunoglobulin structure and function.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	4831970
Pubmed	Nucleotide sequences of class-switch recombination region of the mouse immunoglobulin gamma 2b-chain gene.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	7439686
Pubmed	On immunoglobulin heavy chain gene switching: two gamma 2b genes are rearranged via switch sequences in MPC-11 cells but only one is expressed.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6278424
Pubmed	An Asia-specific variant of human IgG1 represses colorectal tumorigenesis by shaping the tumor microenvironment.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	35133976
Pubmed	Restriction fragment length polymorphism and evolution of the mouse immunoglobulin constant region gamma loci.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	8099342
Pubmed	Ubiquitination of IgG1 cytoplasmic tail modulates B-cell signalling and activation.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	32006024
Pubmed	Strong antigenic selection shaping the immunoglobulin heavy chain repertoire of B-1a lymphocytes in lambda 2(315) transgenic mice.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	12209645
Pubmed	Sequence of the cloned gene for the constant region of murine gamma 2b immunoglobulin heavy chain.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	117549
Pubmed	Cloning immunoglobulin gamma 2b chain gene of mouse: characterization and partial sequence determination.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	116231
Pubmed	Highly reduced binding to high and low affinity mouse Fc gamma receptors by L234A/L235A and N297A Fc mutations engineered into mouse IgG2a.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	25451975
Pubmed	Nucleotide sequences of gene segments encoding membrane domains of immunoglobulin gamma chains.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6283537
Pubmed	Somatic mutation in genes for the variable portion of the immunoglobulin heavy chain.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6801765
Pubmed	Immunoglobulin diversity: analysis of the germ-line VH gene repertoire of the murine anti-GAT response.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6306571
Pubmed	The molecular and biochemical characterization of mutant monoclonal antibodies with increased antigen binding.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	1672339
Pubmed	Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	1713710
Pubmed	Structure of the constant and 3' untranslated regions of the murine Balb/c gamma 2a heavy chain messenger RNA.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6777755
Pubmed	The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	9103199
Pubmed	Gene conversion and polymorphism: generation of mouse immunoglobulin gamma 2a chain alleles by differential gene conversion by gamma 2b chain gene.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6297797
Pubmed	Evolution of immunoglobulin subclasses. Primary structure of a murine myeloma gamma1 chain.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	98524
Pubmed	Immunoglobulin heavy constant gamma 1 silencing decreases tonicity-responsive enhancer-binding protein expression to alleviate diabetic nephropathy.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	38268239
Pubmed	Gene segments encoding transmembrane carboxyl termini of immunoglobulin gamma chains.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6799207
Pubmed	Comparison of mouse immunoglobulin gamma 2a and gamma 2b chain genes suggests that exons can be exchanged between genes in a multigenic family.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6787604
Pubmed	Multiple differences between the nucleic acid sequences of the IgG2aa and IgG2ab alleles of the mouse.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6170065
Pubmed	Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	19703988
Pubmed	Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6767246
Pubmed	Determination of the interface of a large protein complex by transferred cross-saturation measurements.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	12051834
Pubmed	The gamma 1 heavy chain gene includes all of the cis-acting elements necessary for expression of properly regulated germ-line transcripts.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	8683112
Pubmed	Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	807855
Pubmed	Identification of a gene locus for gamma-G-1 immunoglobulin H chains and its linkage to the H chain chromosome region in the mouse.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	4166666
Pubmed	Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infection.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	26201558
Pubmed	Molecular cloning of mouse immunoglobulin heavy chain messenger ribonucleic acids coding for mu, alpha, gamma 1, gamma 2a, and gamma 3 chains.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6249338
Pubmed	mRNA for surface immunoglobulin gamma chains encodes a highly conserved transmembrane sequence and a 28-residue intracellular domain.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6804950
Pubmed	Integrin-dependent organization and bidirectional vesicular traffic at cytotoxic immune synapses.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	19592272
Pubmed	Attenuation of Trypanosoma brucei is associated with reduced immunosuppression and concomitant production of Th2 lymphokines.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	10720538
Pubmed	Elucidation of the enigmatic IgD class-switch recombination via germline deletion of the IgH 3' regulatory region.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	24752300
Pubmed	Variable-region-identical antibodies differing in isotype demonstrate differences in fine specificity and idiotype.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	15699144
Pubmed	Sequence and polyadenylation site determination of the murine immunoglobulin gamma 2a membrane 3' untranslated region.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	2513486
Pubmed	Increased number of T cells and exacerbated inflammatory pathophysiology in a human IgG4 knock-in MRL/lpr mouse model.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	36763580
Pubmed	Independent immunoglobulin class-switch events occurring in a single myeloma cell line.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	3921826
Pubmed	The complete nucleotide sequence of mouse immunoglobin gamma 2a gene and evolution of heavy chain genes: further evidence for intervening sequence-mediated domain transfer.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6262729
Pubmed	Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	26683050
Pubmed	Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA.	IGHG1 IGHG2 IGHG3 IGHG4	1.04e-09	4	199	4	6766534
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	SPNS1 GBF1 ACO2 UPK3B SLC46A1 MSMO1 ZNRF3 PYCR3 BICC1 ABCC10 PLEKHG4 DYNC2H1 SPTLC2 LDAF1 ARFGEF1 ALG11 CPD HUWE1 AREG TSKU CS SLC25A2 SLC2A6 SLC22A5 AGMAT	2.48e-09	1061	199	25	33845483
Pubmed	BTG1 mutation yields supercompetitive B cells primed for malignant transformation.	IGHG1 IGHG2 IGHG3 IGHG4 LY75	2.62e-09	11	199	5	36656933
Pubmed	Exon shuffling generates an immunoglobulin heavy chain gene.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	6769120
Pubmed	Chromosomal location of the structural gene cluster encoding murine immunoglobulin heavy chains.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	6770027
Pubmed	Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	7704573
Pubmed	Channel catfish soluble FcmuR binds conserved linear epitopes present on Cmu3 and Cmu4.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	20031218
Pubmed	A novel allele for inducible Cre expression in germinal center B cells.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	30359469
Pubmed	FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	9834201
Pubmed	The synthesis and processing of the messenger RNAs specifying heavy and light chain immunoglobulins in MPC-11 cells.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	103631
Pubmed	CCAAT/enhancer binding protein β Induces Post-Switched B Cells to Produce Blimp1 and Differentiate into Plasma Cells.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	33163250
Pubmed	Protein arginine methyltransferase 1 regulates B cell fate after positive selection in the germinal center in mice.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	37310381
Pubmed	Mouse models of human multiple myeloma subgroups.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	36853944
Pubmed	IgE knock-in mice suggest a role for high levels of IgE in basophil-mediated active systemic anaphylaxis.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	23423996
Pubmed	The disulphide bridges of a mouse immunoglobulin G1 protein.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	5073237
Pubmed	Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	35044826
Pubmed	Sequential class switching is required for the generation of high affinity IgE antibodies.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	22249450
Pubmed	The FOXO1 Transcription Factor Instructs the Germinal Center Dark Zone Program.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	26620759
Pubmed	Expression of NrasQ61R and MYC transgene in germinal center B cells induces a highly malignant multiple myeloma in mice.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	32640012
Pubmed	Serine-threonine kinase ROCK2 regulates germinal center B cell positioning and cholesterol biosynthesis.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	32229726
Pubmed	Brg1 Supports B Cell Proliferation and Germinal Center Formation Through Enhancer Activation.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	34539636
Pubmed	Rate of replication of the murine immunoglobulin heavy-chain locus: evidence that the region is part of a single replicon.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	3031474
Pubmed	Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain human FCGRT transgenic mice.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	33025844
Pubmed	Evidence that High-Affinity IgE Can Develop in the Germinal Center in the Absence of an IgG1-Switched Intermediate.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	36779803
Pubmed	Organization, structure, and assembly of immunoglobulin heavy chain diversity DNA segments.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	6798155
Pubmed	IgG1 cytoplasmic tail is essential for cell surface expression in Igβ down-regulated cells.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	24548411
Pubmed	Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	6781756
Pubmed	YY1 Is Required for Germinal Center B Cell Development.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	27167731
Pubmed	Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	9743367
Pubmed	Molecular and cellular basis of the retrovirus resistance in I/LnJ mice.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	16301663
Pubmed	Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response.	IGHG1 IGHG2 IGHG3 IGHG4	5.18e-09	5	199	4	9707605
Pubmed	Id3 Orchestrates Germinal Center B Cell Development.	IGHG1 IGHG2 IGHG3 IGHG4	1.55e-08	6	199	4	27457619
Pubmed	Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition.	IGHG1 IGHG2 IGHG3 IGHG4	1.55e-08	6	199	4	30705065
Pubmed	Unexpected effects of different genetic backgrounds on identification of genomic rearrangements via whole-genome next generation sequencing.	IGHG1 IGHG2 IGHG3 IGHG4	1.55e-08	6	199	4	27769169
Interaction	PCDHGB3 interactions	PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	6.01e-07	8	197	4	int:PCDHGB3
Interaction	TOP3B interactions	GBF1 NUP85 GTPBP6 PCNX3 TRIO MYCBP2 SLCO4A1 CUL9 TMEM187 BCR TBC1D24 JAK3 PLEKHG1 ZNRF3 XRN1 PCYT2 POLL MMS19 YTHDF2 ABCC10 RBM38 NPC1 HSPG2 L1CAM GRID1 CFAP43 HUWE1 SHANK2 MTHFR PCNX4 CSPG4 MARK4 HELZ2 PUM1 ZC3HAV1	7.77e-07	1470	197	35	int:TOP3B
Interaction	SCGB1D1 interactions	ADGRV1 WDR54 POLL PTPRU SEMA4G IGHG1 IGHG2 SLC2A6 IGHG4	6.50e-06	133	197	9	int:SCGB1D1
Cytoband	5q31	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 SLC25A2	1.17e-05	115	199	6	5q31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q31	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 SLC25A2 SLC22A5	3.45e-04	298	199	7	chr5q31
GeneFamily	Solute carriers	SLCO4A1 SLC24A3 SLC28A3 SLC46A1 SLC25A35 MTCH2 SLC7A4 SLC26A7 SLC25A2 SLC2A6 SLC25A15 SLC22A5	2.84e-05	395	130	12	752
GeneFamily	Clustered protocadherins	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	9.66e-05	64	130	5	20
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	TRIO BCR PLEKHG1 PLEKHG4 ARHGEF18	1.12e-04	66	130	5	722
GeneFamily	Blood group antigens\|CD molecules\|Proteoglycans	HSPG2 CSPG4	1.05e-03	7	130	2	570
ToppCell	CF-Lymphoid-B_cell\|Lymphoid / Disease state, Lineage and Cell class	TRIO MYCBP2 ITGAX PLEKHG1 ARID5B COL4A4 DUSP4 IGHG1 IGHG2 IGHG3 TMEM131	1.17e-09	193	198	11	7ebf20344a9a154fd2cffa281526867fcf0aded3
ToppCell	mild_COVID-19-NK_CD56bright\|World / disease group, cell group and cell class (v2)	CDHR1 ITGAX IL18RAP SEMA3A TTLL10 RBM38 DUSP4 AREG TIE1 IL7R	1.01e-08	183	198	10	9a4899afac0f91203209392c5f67b3d0aa356b86
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PLEKHG1 ARID5B CNR1 RBM38 COL4A4 DUSP4 IGHG1 IGHG2 IGHG3 IGHG4	1.68e-08	193	198	10	bcda1fb3db7d4c276e3370250a2b79fedd807fc5
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PLEKHG1 ARID5B CNR1 RBM38 COL4A4 DUSP4 IGHG1 IGHG2 IGHG3 IGHG4	1.68e-08	193	198	10	befab58da635723db4f9270d087afa981fc45bf1
ToppCell	Control-B_cell-B_cell\|Control / Disease group,lineage and cell class （2021.01.30）	PLEKHG1 ARID5B CNR1 RBM38 COL4A4 DUSP4 IGHG1 IGHG2 IGHG3 IGHG4	1.68e-08	193	198	10	d43099c0b8ca68048d6497c4db89d6d5155375f9
ToppCell	BAL-Control-Lymphocyte-B-B_cell\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PLEKHG1 ARID5B CNR1 RBM38 COL4A4 DUSP4 IGHG1 IGHG2 IGHG3 IGHG4	1.68e-08	193	198	10	ba826e6e035e48e1b497af1081c43339b0019e76
ToppCell	Control-B_cell\|Control / Disease group,lineage and cell class （2021.01.30）	PLEKHG1 ARID5B CNR1 RBM38 COL4A4 DUSP4 IGHG1 IGHG2 IGHG3 IGHG4	1.77e-08	194	198	10	8388fe4df3461d85b21bd6847a4d32c030aaece4
ToppCell	Control-Lymphoid-Plasma,_B_cells\|Control / Condition, Lineage and Cell class	PLEKHG1 ARID5B RBM38 COL4A4 DUSP4 IGHG1 IGHG2 IGHG3 IGHG4 AGMAT	1.77e-08	194	198	10	31fff4361ebed6308b1e6b2b705ee6e0a695bd0c
ToppCell	BAL-Control-Lymphocyte-B\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PLEKHG1 ARID5B CNR1 RBM38 COL4A4 DUSP4 IGHG1 IGHG2 IGHG3 IGHG4	1.77e-08	194	198	10	1537e2285d0a8d0a4175dd0b8b1d1ccd887229fc
ToppCell	PBMC-Severe\|PBMC / Compartment, Disease Groups and Clusters	JAK3 ARID5B DDX60L SPTLC2 AREG IGHG1 IGHG2 IGHG3 IGHG4 SIGLEC1	2.25e-08	199	198	10	b428d95d3c90b28f658f652a768588a8ced4abd9
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-B_atypical-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZNF140 PLEKHG1 PTPRB ARID5B MPPED2 MAP4K3 NCKIPSD RASGRP1 ZBTB46	1.15e-07	179	198	9	5be883d7d0be3180bb9844e4a757f0dd247294e4
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast\|COVID-19_Severe / Disease, condition lineage and cell class	PGM3 BUB1 VARS1 COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	2.82e-07	199	198	9	e6422b65e22e5aa8dfaebdae5be76dd78b978604
ToppCell	COVID-19_Moderate\|World / disease group, cell group and cell class	ARID5B XRN1 RASGRP1 IGHG1 IGHG2 IGHG3 IGHG4 HELZ2 IL7R	2.82e-07	199	198	9	952fac67588ad5676f5939e3c7f8bac803c27064
ToppCell	390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells)	DDN ACAD11 C11orf68 DEGS2 ZCWPW1 PLEKHG4 OSR2 LAMC1	4.60e-07	154	198	8	1c62290a2558fd6401b27de5a867d243b143b00a
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A4 LAMC1 LRRC9 IGHG1 SLC25A2 IGHG2 IGHG3 IGHG4	6.76e-07	162	198	8	8278dccdb139396ede34b83b02ebce837f2489d6
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	ABCA12 SLCO4A1 SEMA3A PLEKHG1 PYCR3 ITGA10 ZBTB46 TIE1	1.02e-06	171	198	8	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_mature_DC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CSMD3 SEMA3A PLEKHG1 PLEKHG4 DUSP4 ARHGEF18 LY75 IL7R	1.02e-06	171	198	8	341f9f79c1ed654ab347e25dc4936f89ffdf9617
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCR ALS2CL DLG2 PLXDC1 PCDHGB2 GPAM TMEM131 IL7R	1.26e-06	176	198	8	29cda51a99100ddd2928cadc92da40f001d7e1f4
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-early_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCR ALS2CL DLG2 PLXDC1 PCDHGB2 GPAM TMEM131 IL7R	1.26e-06	176	198	8	01774a86d7d92f31a056b753f9844f923038003e
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	APCDD1 ENPP2 SLCO4A1 PTPRB HSPG2 MEIOC SLC2A6 ZNF74	1.26e-06	176	198	8	1df7b6ce2519ad99bacbbaf1a8d5929e11513faa
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO PGM3 BUB1 COL4A4 LAMC1 IGHG1 IGHG3 IGHG4	1.37e-06	178	198	8	693f1135d9c5545945e80c7ba3d098afc0ccac29
ToppCell	mild_COVID-19-NK_CD56bright\|mild_COVID-19 / disease group, cell group and cell class (v2)	CDHR1 ITGAX IL18RAP SEMA3A TTLL10 DUSP4 AREG TIE1	1.49e-06	180	198	8	d8b418edd807a51c0b5f4018b8b478dcc65892a7
ToppCell	severe_influenza-B_memory\|severe_influenza / disease group, cell group and cell class (v2)	ARID5B CNR1 COL4A4 MUC16 IGHG1 IGHG2 IGHG3 IGHG4	1.56e-06	181	198	8	92e572c92109a6dae0f73138c57c3bbd2e0a2f36
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SPNS2 CHAT BCR TBC1D24 SEMA3A PTPRB ZAN TIE1	1.62e-06	182	198	8	d22ab50b135482915687c70e6dad29bfe2bb2c68
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 ADGRV1 CSMD3 ADAMTS16 DNAH9 ZAN GRID1 CSMD1	1.76e-06	184	198	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 ADGRV1 CSMD3 ADAMTS16 DNAH9 ZAN GRID1 CSMD1	1.76e-06	184	198	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ENPP2 SPNS2 SLCO4A1 PLEKHG1 PTPRB HSPG2 TIE1 CSMD1	1.76e-06	184	198	8	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA12 ADGRV1 CSMD3 ADAMTS16 DNAH9 ZAN GRID1 CSMD1	1.76e-06	184	198	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID-19_Mild-Lymphoid_T/NK-NK_CD56bright\|COVID-19_Mild / Disease group, lineage and cell class	CDHR1 ITGAX IL18RAP TTLL10 DUSP4 AREG TIE1 IL7R	1.76e-06	184	198	8	f67308228bb6a5d624279fbb04db25a2f4087c9b
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CDHR1 ITGAX IL18RAP TTLL10 DUSP4 AREG TIE1 IL7R	1.83e-06	185	198	8	df5d2309d19ac8d5e429afa785d0a480e75a8f9e
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CDHR1 ITGAX IL18RAP TTLL10 DUSP4 AREG TIE1 IL7R	1.83e-06	185	198	8	3a046c948524e5d0e986cd645e318d6930d7e0ee
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	CDHR1 ITGAX IL18RAP TTLL10 DUSP4 AREG TIE1 IL7R	1.83e-06	185	198	8	71d1a771026d9fa3528d46ac3d11353e396f2d87
ToppCell	PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CDHR1 ITGAX IL18RAP TTLL10 DUSP4 AREG TIE1 IL7R	1.83e-06	185	198	8	37b48218dd523049b57b13eb9cdb34e106cf91ea
ToppCell	LV-10._Endothelium_II\|World / Chamber and Cluster_Paper	SPNS2 SLCO4A1 BCR PLEKHG1 PTPRB HSPG2 ITGA10 TIE1	1.99e-06	187	198	8	7876dcb4800c2e54874df3d933efb79307a64a97
ToppCell	COVID-19_Severe-B_memory\|World / disease group, cell group and cell class	PLEKHG1 ARID5B COL4A4 L1CAM IGHG1 IGHG2 IGHG3 IGHG4	1.99e-06	187	198	8	f29c71f2505bb64f3010ada491d422b87a6f7db3
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PLEKHG1 PTPRB MPPED2 FAM135A HSPG2 DUSP4 TIE1 CSMD1	2.15e-06	189	198	8	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-\|bone_marrow / Manually curated celltypes from each tissue	CDHR1 ITGAX IL18RAP TTLL10 RBM38 AREG SERPINA11 TIE1	2.15e-06	189	198	8	6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5
ToppCell	CF-Lymphoid-B_cell\|CF / Disease state, Lineage and Cell class	MYCBP2 PLEKHG1 COL4A4 RASGRP1 IGHG1 IGHG2 IGHG3 IGHG4	2.24e-06	190	198	8	374d8fd63c733178acab07682ed1519693efab45
ToppCell	COVID-19_Moderate-Plasmablast\|World / disease group, cell group and cell class	PGM3 BUB1 COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	2.33e-06	191	198	8	bb28703020c5296b65527094d2e5924348275e58
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPNS2 SEMA3A DCLRE1A DEGS2 PLXNB1 AMN MUC16 FAN1	2.42e-06	192	198	8	8899d81306770adda893b5e146df1253971754c5
ToppCell	COVID-19_Moderate-Plasmablast\|COVID-19_Moderate / disease group, cell group and cell class	PGM3 BUB1 COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	2.42e-06	192	198	8	25c6c7a244190f82c7feab874bdec12490b7de4d
ToppCell	COVID-19_Severe-Plasmablast\|World / disease group, cell group and cell class	BUB1 COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4 TP73	2.42e-06	192	198	8	a333053fe2bd206c32790916bfc5fce904ab7f57
ToppCell	saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	SPNS2 SEMA3A DCLRE1A DEGS2 PLXNB1 AMN MUC16 FAN1	2.42e-06	192	198	8	5fda9a465c9f77c7fa1a3ea07a2b0374bbc23b2a
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BUB1 VARS1 COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	2.51e-06	193	198	8	ce3873ece35fd2155ea235cb3c8bcd235cc0ebde
ToppCell	PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BUB1 VARS1 COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	2.51e-06	193	198	8	8f57b0473a2c2c07f83e5fe70f16862b1bb3b514
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ENPP2 DLG2 DLG3 BICC1 HSPG2 OSR2 GPAM PI15	2.51e-06	193	198	8	64edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCell	PBMC-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PLEKHG1 BUB1 COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	2.61e-06	194	198	8	bd2c53fb064edfec76abe56a9ffaced0bda32ab0
ToppCell	PBMC-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PLEKHG1 BUB1 COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	2.61e-06	194	198	8	7dbedbdece4271e10134c9338c85cb3e04484c75
ToppCell	PBMC-Mild-cDC_1\|Mild / Compartment, Disease Groups and Clusters	ITGAX DDX60L SPTLC2 IGHG1 IGHG3 IGHG4 HELZ2 SIGLEC1	2.71e-06	195	198	8	674355ca00314bde90ef7f6ddb83afe2d5323130
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-B\|COVID-19_Severe / Disease, condition lineage and cell class	PLEKHG1 BUB1 COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	3.04e-06	198	198	8	1831a777dd996c25f637d551d754ec1b9c23feb2
ToppCell	3'-Distal_airway-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SPNS2 SLCO4A1 PLEKHG1 PTPRB TCAF2 TIE1 HELZ2 IL7R	3.04e-06	198	198	8	5eedcc20e35adbabe268a93b748ee4566b3ffb66
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-B-Plasmablast\|COVID-19_Mild / Disease, condition lineage and cell class	PGM3 BUB1 COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	3.15e-06	199	198	8	46f31aef26c3da7608082f750d743ad54adbc51a
ToppCell	Influenza-Influenza_Severe-Lymphocyte-B\|Influenza_Severe / Disease, condition lineage and cell class	PLEKHG1 ARID5B RBM38 COL4A4 IGHG1 IGHG2 IGHG3 IGHG4	3.27e-06	200	198	8	bf238a0a074d6c5cba8cb73d3b715ee701a612b6
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	MYCBP2 ARID5B XRN1 RBM38 AREG IGHG1 IGHG3 IGHG4	3.27e-06	200	198	8	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FAM135A COL4A4 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	4.35e-06	147	198	7	22d71cf92b957e5a8aa63b13157626d013d6752b
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_E\|367C / Donor, Lineage, Cell class and subclass (all cells)	IL18RAP TTLL10 VARS1 ZBTB2 AREG SERPINA11 IL7R	4.76e-06	149	198	7	f18bddc84b064f3d57a1281d5172c404d87f25da
ToppCell	facs-Marrow-KLS-18m-Lymphocytic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC28A3 ADGRV1 ITGAX PTPRB TBX10 BICC1 HSPG2	5.91e-06	154	198	7	37765512dfae557b9f6eb30a29463b93682a4404
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	COL4A4 LAMC1 LRRC9 IGHG1 SLC25A2 IGHG2 IGHG3	6.17e-06	155	198	7	881422c57d230c0e2e5f9098ab888caa94ca61aa
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA12 SLC28A3 ADAMTS16 MPPED2 DYNC2H1 MAP4K3 TRPV5	6.71e-06	157	198	7	2c5295043611bac7dfa4aef2146681bce4a33a8f
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-ILC2\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DDN IL18RAP DUSP4 SYT16 RASGRP1 SLC2A6 IL7R	7.91e-06	161	198	7	a3318e738836eb1c5babe1a5d2dd7fa34d732662
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ADGRV1 CSMD3 BUB1 DNAH9 ZAN CCKBR SIGLEC1	8.24e-06	162	198	7	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Influenza_Severe-B_memory\|World / Disease group and Cell class	COL4A4 MUC16 SEMA4G IGHG1 IGHG2 IGHG3 IGHG4	8.24e-06	162	198	7	21eb96cd4fecd85dd6acbbc3760944fa1a7cff42
ToppCell	Control-Lymphocyte-B-Plasmablast\|Control / Disease, Lineage and Cell Type	DDN BUB1 COL4A4 IGHG1 IGHG2 IGHG3 IGHG4	8.24e-06	162	198	7	67b32c40cc180c5ebbfd901a417b5be469500110
ToppCell	normal-na-Lymphocytic_NK-NK_bright-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	CDHR1 DDN IL18RAP PI15 AREG SERPINA11 ZBTB46	8.92e-06	164	198	7	b5a91f2cbfad9a2bc38aea576085a37865df955d
ToppCell	Influenza_Severe-B_memory\|Influenza_Severe / Disease group and Cell class	COL4A4 MUC16 SEMA4G IGHG1 IGHG2 IGHG3 IGHG4	9.28e-06	165	198	7	51172acaeb667b34b8b8c7878d67cfa0c4a2dffc
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS16 MPPED2 MAP4K3 LRRC9 SLC26A7 PCNX4 TRPV5	9.28e-06	165	198	7	9bd332e5ede759a00a47728ea5558c215efdd77a
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GTPBP6 GGCX DLG2 B3GLCT ZAN GRID1 ZBTB46	9.28e-06	165	198	7	0edd56e8d14eaeced9882dd9206ea93e8f402e8d
ToppCell	facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GTPBP6 GGCX DLG2 B3GLCT ZAN GRID1 ZBTB46	9.28e-06	165	198	7	fa3aadfff6fb1e7f142db333c60c2cba02b17e6c
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	WDR54 DEGS2 DNAH9 DYNC2H1 MUC16 CFAP43 PCNX4	1.00e-05	167	198	7	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	TMEM187 VARS1 ZBTB2 SERPINA11 ZBTB46 MARK4 IL7R	1.00e-05	167	198	7	b5d15773be32cd277125fd3b4056a8fefaefa5ec
ToppCell	P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PCNX3 SLCO4A1 SLC24A3 NPC1 COL4A4 MTHFR PRORP	1.00e-05	167	198	7	5c3d0763f73628c71c71f9883556bb4f1639f3cc
ToppCell	droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPNS2 CYP27A1 SLCO4A1 ADAMTS16 TCAF2 ZBTB46 SHANK2	1.00e-05	167	198	7	3c06894fc6177f3c204094719904da42f08b9af8
ToppCell	IIH-naiveBc\|IIH / Condition, Cell_class and T cell subcluster	TRIO CNR1 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	1.04e-05	168	198	7	8450ed6720d308c711dfbc76652e5821be7b8e93
ToppCell	IIH-naiveBc-\|IIH / Condition, Cell_class and T cell subcluster	TRIO CNR1 LAMC1 IGHG1 IGHG2 IGHG3 IGHG4	1.04e-05	168	198	7	27b500f79aedc4669988670c92ff1a47dcbdf2a0
ToppCell	COVID-19_Moderate-NK_CD56bright\|World / disease group, cell group and cell class	CDHR1 ITGAX IL18RAP TTLL10 AREG TIE1 IL7R	1.13e-05	170	198	7	caa6a534c1e9639caced9a51680f5c905f061bcc
ToppCell	COVID-19_Severe-NK_CD56bright\|COVID-19_Severe / Disease condition and Cell class	CDHR1 ITGAX IL18RAP TTLL10 AREG TIE1 ZFHX3	1.17e-05	171	198	7	5810f790012a0750ca3378595514f66a99f123be
ToppCell	facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	INPP4B ZBTB2 RASGRP1 IKBKE TTC21B LY75 IL7R	1.17e-05	171	198	7	f1fdc0ec3399ed6955976d02be7e5fc329a64276
ToppCell	droplet-Spleen-nan-18m-Myeloid-macrophage_dendritic_cell_progenitor\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDN SLCO4A1 NPC1 COL17A1 PLXDC1 NCKIPSD ZFHX3	1.17e-05	171	198	7	4e856441063e9825b6f87a1d3dd19c77dae4662c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PLEKHG1 DUSP4 IGHG1 SLC25A2 IGHG2 IGHG3 IGHG4	1.17e-05	171	198	7	a2938e56cb5749004317798dc7ac0f0c2d4d8ae0
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-Alox5+_Lymphocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XYLT1 C11orf68 PPOX RASGRP1 MARK4 IL7R ZC3HAV1	1.26e-05	173	198	7	4c788c1dad1da495b3b5c10f95e779848dfe85dc
ToppCell	mild_COVID-19_(asymptomatic)-B_memory\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	ARID5B COL4A4 AMN IGHG1 IGHG2 IGHG3 IGHG4	1.26e-05	173	198	7	9082ad77b44f65b72094df6e502cce81b62fe81a
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	SLCO4A1 SETMAR ZCWPW1 B3GLCT PLXDC1 MARK4 IL7R	1.26e-05	173	198	7	090dc3c5bd2652a65c2490fc889da858c3af368f
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-lymphocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XYLT1 C11orf68 PPOX RASGRP1 MARK4 IL7R ZC3HAV1	1.26e-05	173	198	7	6e92983d9f8a2a37f23e60a0d5bb1738217897bc
ToppCell	ASK428-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	UPK3B SLCO4A1 MUC16 ALG11 IGHG1 IGHG3 CSMD1	1.36e-05	175	198	7	e0979e5795a49b4e5c9b88e7fe6b7bda7a413a6c
ToppCell	facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	INPP4B ZCWPW1 AREG LRRC9 RASGRP1 SHANK2 IL7R	1.46e-05	177	198	7	1730e640986e50943bd781b7d949bcc5b7c12dde
ToppCell	facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte-Alox5+_lymphocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	INPP4B ZCWPW1 AREG LRRC9 RASGRP1 SHANK2 IL7R	1.46e-05	177	198	7	b7cfa3776f58377e35830780650d236b5cceecee
ToppCell	367C-Myeloid-Dendritic-cDC_activated\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MPPED2 CNR1 COL17A1 DUSP4 PTPRU LY75 IL7R	1.46e-05	177	198	7	a0ff337f11bdb11959ac71805ff94be6b4ec1083
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TRIO PGM3 BUB1 COL4A4 IGHG1 IGHG3 IGHG4	1.52e-05	178	198	7	6765c6970b1f2b719a20d2afd7471e1c262f3fc4
ToppCell	Severe-CD4+_T_activated\|World / Disease group and Cell class	APCDD1 ARID5B XRN1 DDX60L DNAH9 HELZ2 IL7R	1.52e-05	178	198	7	ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCell	COVID-19_Mild-NK_CD56bright\|COVID-19_Mild / Disease condition and Cell class	CDHR1 ITGAX IL18RAP TTLL10 AREG TIE1 ZFHX3	1.58e-05	179	198	7	90e7a4af195aa2332b07a9f06cde63e72ff49255
ToppCell	BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	INPP4B JAK3 TCAF2 PLXDC1 SLC25A15 PRORP IL7R	1.58e-05	179	198	7	a634ca46ffc394c5f5215fc5d8eae4a77819af9c
ToppCell	CTRL-Lymphoid-B_cell\|CTRL / Disease state, Lineage and Cell class	PLEKHG1 CNR1 COL4A4 IGHG1 IGHG2 IGHG3 IGHG4	1.58e-05	179	198	7	dd4055c0a8360ea10323ef6249519a6ae08fc05a
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ENPP2 BCR PLEKHG1 PTPRB MPPED2 HSPG2 TIE1	1.58e-05	179	198	7	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell	BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	INPP4B JAK3 TCAF2 PLXDC1 SLC25A15 PRORP IL7R	1.58e-05	179	198	7	35f014b6e752626909d829c5ab9bb761c1f3e3dc
ToppCell	AT1_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	UPK3B ALS2CL PLXNB1 COL4A4 HSPG2 SYT16 SLC7A4	1.58e-05	179	198	7	1603117b52623663458a977c94bf7f9f6c1114b8
ToppCell	IPF-Lymphoid-B\|World / Disease state, Lineage and Cell class	PLEKHG1 ARID5B CNR1 ARHGEF18 IGHG1 IGHG2 IGHG3	1.63e-05	180	198	7	30f9398c9b784f49470847a025bac90687e997a1
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	INPP4B LSMEM2 PLXDC1 PI15 SLC26A7 DNAH17 ZFHX3	1.63e-05	180	198	7	4fb95ed39508bede5472dd36aeabe91b33631726
ToppCell	COVID-19-T_cells-Tregs\|COVID-19 / group, cell type (main and fine annotations)	INPP4B JAK3 ARID5B RASGRP1 LY75 IL7R ZC3HAV1	1.69e-05	181	198	7	534659cf754326c6a73c0daa30e9d610612a0292
ToppCell	Healthy-B_memory\|Healthy / disease group, cell group and cell class	PLEKHG1 ARID5B COL4A4 IGHG1 IGHG2 IGHG3 IGHG4	1.69e-05	181	198	7	7b903076efb90026b9845af0c7a840901451193a
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MPPED2 HSPG2 ZCWPW1 L1CAM ITGA10 CSPG4 CSMD1	1.75e-05	182	198	7	a1c0e4090a9e7aa4941a40c817d178de144888b6
Disease	mental development measurement	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1	5.29e-07	25	192	5	EFO_0008230
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 CS	7.07e-06	71	192	6	EFO_0007878, EFO_0007979
Disease	lymphocyte count	GBF1 TMEM187 BCR IL18RAP INPP4B ZNRF3 ARID5B DDX60L VARS1 AMN ZAN PCDHGB6 PCDHGB5 PLXDC1 PCDHGB3 PCDHGB2 PCDHGB1 ARHGEF18 IKBKE DNAH17 SLC22A5 MARK4 SIGLEC1 IL7R ZC3HAV1	1.04e-05	1464	192	25	EFO_0004587
Disease	ornithine translocase deficiency (implicated_via_orthology)	SLC25A2 SLC25A15	4.21e-05	2	192	2	DOID:0050720 (implicated_via_orthology)
Disease	neural cell adhesion molecule 1 measurement	IGHG1 IGHG3	4.21e-05	2	192	2	EFO_0801826
Disease	insulin growth factor-like family member 4 measurement	IGHG1 IGHG3	4.21e-05	2	192	2	EFO_0801701
Disease	immunoglobulin G measurement	IGHG2 IGHG4	4.21e-05	2	192	2	EFO_0020465
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	BCR JAK3 ARID5B MTHFR IL7R	4.90e-05	61	192	5	C1961102
Disease	Antihypertensive use measurement	ETFDH PLEKHG1 ZNRF3 MPPED2 BICC1 ABCC10 HSPG2 ARHGEF18 AREG	6.43e-05	265	192	9	EFO_0009927
Disease	Calcium channel blocker use measurement	NEIL2 PLEKHG1 BICC1 ABCC10 B3GLCT ARHGEF18 ZBTB46 MTHFR	8.21e-05	213	192	8	EFO_0009930
Disease	ameloblastin measurement	IGHG1 IGHG3	1.26e-04	3	192	2	EFO_0801377
Disease	paired immunoglobulin-like type 2 receptor alpha measurement	IGHG1 IGHG3	1.26e-04	3	192	2	EFO_0801866
Disease	sphingolipidosis (implicated_via_orthology)	SPNS1 SPNS2	1.26e-04	3	192	2	DOID:1927 (implicated_via_orthology)
Disease	secretoglobin family 1C member 1 measurement	IGHG1 IGHG3	1.26e-04	3	192	2	EFO_0802041
Disease	mean platelet volume	PCNX3 SLC24A3 SHKBP1 STRN CLIC1 DLG3 RBM38 ZAN PCDHGB6 PCDHGB5 PCDHGB3 PCDHGB2 PCDHGB1 MEIOC MTHFR SLC22A5 MARK4 LY75	1.30e-04	1020	192	18	EFO_0004584
Disease	Tinnitus	PCNX3 ITGAX ARID5B DLG2 SYT16 TMEM131	2.15e-04	130	192	6	HP_0000360
Disease	cardiovascular disease	PRSS36 PLEKHG1 C22orf31 ARID5B DLG2 BICC1 ABCC10 NPC1 B3GLCT ARHGEF18 GRID1	2.17e-04	457	192	11	EFO_0000319
Disease	di-N-acetylchitobiase measurement	IGHG1 IGHG3	2.51e-04	4	192	2	EFO_0801524
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	2.51e-04	4	192	2	cv:C0265275
Disease	trem-like transcript 4 protein measurement	IGHG1 IGHG3	2.51e-04	4	192	2	EFO_0802160
Disease	sodium/potassium-transporting ATPase subunit alpha-1 measurement	IGHG1 IGHG3	2.51e-04	4	192	2	EFO_0802077
Disease	RING finger protein 165 measurement	IGHG1 IGHG3	2.51e-04	4	192	2	EFO_0802027
Disease	age-related hearing impairment	CSMD3 TBC1D24 XYLT1 ARID5B DLG2 ABCC10 PCNX4 CSMD1 ZRANB1	2.90e-04	324	192	9	EFO_0005782
Disease	Tourette syndrome	CSMD3 XYLT1 MUC16 PTPRU	3.17e-04	50	192	4	EFO_0004895
Disease	Obesity	APCDD1 ETFDH MTCH2 CNR1 NPC1 CS ZFHX3	4.08e-04	205	192	7	C0028754
Disease	potassium voltage-gated channel subfamily E member 2 measurement	IGHG1 IGHG3	4.16e-04	5	192	2	EFO_0801901
Disease	response to allogeneic hematopoietic stem cell transplant, donor genotype effect measurement, mortality	ARID5B PCNX4	4.16e-04	5	192	2	EFO_0004352, EFO_0007044, EFO_0007892
Disease	Myositis, Proliferative	IGHG1 IGHG2	4.16e-04	5	192	2	C0544796
Disease	estrogen measurement, response to aromatase inhibitor	DLG2 CSMD1	4.16e-04	5	192	2	EFO_0011007, GO_0061477
Disease	Infectious Myositis	IGHG1 IGHG2	4.16e-04	5	192	2	C0158353
Disease	protein shisa-3 homolog measurement	IGHG1 IGHG3	4.16e-04	5	192	2	EFO_0801964
Disease	Myositis	IGHG1 IGHG2	4.16e-04	5	192	2	C0027121
Disease	response to trauma exposure, post-traumatic stress disorder symptom measurement	INPP4B GRID1	4.16e-04	5	192	2	EFO_0008483, EFO_0008535
Disease	Myositis, Focal	IGHG1 IGHG2	4.16e-04	5	192	2	C0751357
Disease	Idiopathic Inflammatory Myopathies	IGHG1 IGHG2	4.16e-04	5	192	2	C0751356
Disease	PR interval	PCNX3 MYCBP2 ABCA12 ACO2 CUL9 SEMA3A STRN MPPED2 CNR1 HSPG2 LAMC1	4.27e-04	495	192	11	EFO_0004462
Disease	Sarcosine measurement	PCDHGB3 PCDHGB2 PCDHGB1	4.36e-04	23	192	3	EFO_0021668
Disease	Disorder of eye	CDHR1 CYP27A1 ADGRV1 CLRN1 B3GLCT TTC21B INVS	4.99e-04	212	192	7	C0015397
Disease	spontaneous preterm birth	SLC28A3 DLG2 B3GLCT GRID1 CCKBR	5.29e-04	101	192	5	EFO_0006917
Disease	obesity (implicated_via_orthology)	DEGS2 CNR1 PLXNB1 HDAC6 ABHD4 ZFHX3 PUM1	5.42e-04	215	192	7	DOID:9970 (implicated_via_orthology)
Disease	response to TNF antagonist, joint damage measurement	CSMD3 DLG2 PRORP	5.61e-04	25	192	3	EFO_0004653, EFO_0005413
Disease	Seizures	PNKP CYP27A1 CHAT PCYT2 CNR1 MTHFR PUM1	5.88e-04	218	192	7	C0036572
Disease	carcinoembryonic antigen-related cell adhesion molecule 1 measurement	IGHG1 IGHG3	6.21e-04	6	192	2	EFO_0801456
Disease	beta-sarcoglycan measurement	IGHG1 IGHG3	6.21e-04	6	192	2	EFO_0801422
Disease	multiple coagulation factor deficiency protein 2 measurement	IGHG1 IGHG3	6.21e-04	6	192	2	EFO_0801810
Disease	complement C1q subcomponent measurement	IGHG1 IGHG3	6.21e-04	6	192	2	EFO_0008089
Disease	parenchymal hematoma, response to recombinant tissue-plasminogen activator	SEMA3A ZBTB46	6.21e-04	6	192	2	EFO_0020101, EFO_0600080
Disease	neutropenia, response to metamizole, Drug-induced agranulocytosis	STARD13 PTPRU	6.21e-04	6	192	2	EFO_0010971, HP_0012235, MONDO_0001475
Disease	migraine disorder, pulse pressure measurement	SLC24A3 MPPED2 DYNC2H1	6.32e-04	26	192	3	EFO_0005763, MONDO_0005277
Disease	Ciliopathies	ADGRV1 CLRN1 DYNC2H1 TTC21B INVS	7.80e-04	110	192	5	C4277690
Disease	lumbar disc degeneration	DYNC2H1 SLC26A7 CSMD1	7.88e-04	28	192	3	EFO_0004994
Disease	inducible T-cell costimulator measurement	IGHG1 IGHG3	8.66e-04	7	192	2	EFO_0021967
Disease	Drug habituation	CSMD3 XYLT1 CNR1 TTC21B CSMD1	9.53e-04	115	192	5	C0013170
Disease	Drug abuse	CSMD3 XYLT1 CNR1 TTC21B CSMD1	9.53e-04	115	192	5	C0013146
Disease	Prescription Drug Abuse	CSMD3 XYLT1 CNR1 TTC21B CSMD1	9.53e-04	115	192	5	C4316881
Disease	Substance-Related Disorders	CSMD3 XYLT1 CNR1 TTC21B CSMD1	9.53e-04	115	192	5	C0236969
Disease	Drug Use Disorders	CSMD3 XYLT1 CNR1 TTC21B CSMD1	9.53e-04	115	192	5	C0013222
Disease	Drug Dependence	CSMD3 XYLT1 CNR1 TTC21B CSMD1	9.53e-04	115	192	5	C1510472
Disease	Substance Dependence	CSMD3 XYLT1 CNR1 TTC21B CSMD1	9.53e-04	115	192	5	C0038580
Disease	Substance Use Disorders	CSMD3 XYLT1 CNR1 TTC21B CSMD1	9.53e-04	115	192	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	CSMD3 XYLT1 CNR1 TTC21B CSMD1	9.53e-04	115	192	5	C0029231
Disease	Substance abuse problem	CSMD3 XYLT1 CNR1 TTC21B CSMD1	9.91e-04	116	192	5	C0740858
Disease	NEPHRONOPHTHISIS 2	TTC21B INVS	1.15e-03	8	192	2	C1865872
Disease	benign neoplasm (implicated_via_orthology)	DLG2 DLG3	1.15e-03	8	192	2	DOID:0060072 (implicated_via_orthology)
Disease	Mental Depression	CHAT BICC1 CNR1 HDAC6 DUSP4 GRID1 MTHFR	1.43e-03	254	192	7	C0011570
Disease	Disorder of fatty acid metabolism	ETFDH SLC22A5	1.47e-03	9	192	2	cv:C0268634
Disease	bitter alcoholic beverage consumption measurement	INPP4B ACSS3 NPC1 ZFHX3 CSMD1	1.82e-03	133	192	5	EFO_0010092
Disease	BRCA2 mutation carier statu	STARD13 B3GLCT	1.83e-03	10	192	2	EFO_0011022
Disease	lactose measurement	ARID5B CSMD1	1.83e-03	10	192	2	EFO_0010507
Disease	cystic kidney disease (implicated_via_orthology)	BICC1 TTC21B	1.83e-03	10	192	2	DOID:2975 (implicated_via_orthology)
Disease	axin-2 measurement	IGHG1 IGHG3	1.83e-03	10	192	2	EFO_0801400
Disease	corpus callosum anterior volume measurement	SEMA3A STRN LAMC1	2.09e-03	39	192	3	EFO_0010295
Disease	Jeune thoracic dystrophy	DYNC2H1 TTC21B	2.23e-03	11	192	2	C0265275
Disease	Hyperhomocysteinemia	SLC46A1 MTHFR	2.23e-03	11	192	2	C0598608
Disease	Colorectal Carcinoma	ABCA12 ETFDH CSMD3 BUB1 DLG3 TTLL10 ARFGEF1 LAMC1 GRID1 PTPRU PPOX MTHFR	2.27e-03	702	192	12	C0009402
Disease	urate measurement	SPNS1 PCNX3 ADGRV1 QRICH2 INPP4B C11orf68 DLG2 MPPED2 VARS1 BICC1 COL4A4 SHANK2 CSPG4 AGMAT	2.28e-03	895	192	14	EFO_0004531
Disease	rectum cancer	SLC24A3 INPP4B LAMC1	2.58e-03	42	192	3	EFO_1000657
Disease	hexanoylcarnitine measurement	ETFDH SLC22A5	2.66e-03	12	192	2	EFO_0021040
Disease	polychlorinated biphenyls measurement, gestational serum measurement	BICC1 CCKBR	2.66e-03	12	192	2	EFO_0007042, EFO_0007964
Disease	waist-hip ratio	NUP85 APCDD1 MYCBP2 CUL9 SLC28A3 ZNRF3 ARID5B XRN1 TBX10 DLG2 MPPED2 ABCC10 NPC1 DYNC2H1 ARFGEF1 DNAH17 TP73	2.82e-03	1226	192	17	EFO_0004343
Disease	immunoglobulin isotype switching measurement	ZNRF3 IGHG1 IGHG2	2.95e-03	44	192	3	EFO_0010128
Disease	Depressive disorder	CHAT BICC1 CNR1 HDAC6 DUSP4 GRID1 MTHFR	2.95e-03	289	192	7	C0011581
Disease	matrix metalloproteinase measurement	SLC24A3 DYNC2H1	3.13e-03	13	192	2	EFO_0004744
Disease	Short Rib-Polydactyly Syndrome	DYNC2H1 TTC21B	3.13e-03	13	192	2	C0036996
Disease	Mental Retardation, X-Linked Nonsyndromic	DLG3 HUWE1	3.13e-03	13	192	2	C3501611
Disease	tumor necrosis factor ligand superfamily member 11 measurement	IGHG1 IGHG3	3.13e-03	13	192	2	EFO_0010617
Disease	Nephronophthisis	TTC21B INVS	3.13e-03	13	192	2	C0687120
Disease	nephroblastoma (is_implicated_in)	MTHFR TP73	3.64e-03	14	192	2	DOID:2154 (is_implicated_in)
Disease	neuronal ceroid lipofuscinosis (implicated_via_orthology)	SPNS1 SPNS2	3.64e-03	14	192	2	DOID:14503 (implicated_via_orthology)
Disease	severe combined immunodeficiency (is_implicated_in)	JAK3 IL7R	3.64e-03	14	192	2	DOID:627 (is_implicated_in)
Disease	Saldino-Noonan Syndrome	DYNC2H1 TTC21B	3.64e-03	14	192	2	C0036069
Disease	Majewski Syndrome	DYNC2H1 TTC21B	3.64e-03	14	192	2	C0024507
Disease	serum metabolite measurement	TRIO ETFDH SLC24A3 SLC28A3 ARID5B MTCH2 PYCR3 COL4A4 GPAM DNAH17 SLC22A5 AGMAT ZFHX3 CSMD1	3.70e-03	945	192	14	EFO_0005653
Disease	developmental disorder of mental health (implicated_via_orthology)	DLG2 DLG3 PLXNB1	4.01e-03	49	192	3	DOID:0060037 (implicated_via_orthology)
Disease	Endometrioma	CNR1 OSR2 AREG RASGRP1 IL7R	4.14e-03	161	192	5	C0269102
Disease	Endometriosis	CNR1 OSR2 AREG RASGRP1 IL7R	4.14e-03	161	192	5	C0014175
Disease	corpus callosum volume measurement	SEMA3A STRN MTCH2 LAMC1	4.19e-03	100	192	4	EFO_0010299
Disease	Bipolar Disorder	BCR DLG2 DLG3 CNR1 GRID1 RASGRP1 SHANK2 MTHFR CSMD1	4.20e-03	477	192	9	C0005586
Disease	L2 Acute Lymphoblastic Leukemia	BCR ARID5B MTHFR	4.25e-03	50	192	3	C0023453
Disease	Childhood Acute Lymphoblastic Leukemia	BCR ARID5B MTHFR	4.74e-03	52	192	3	C0023452

Protein segments in the cluster

Peptide	Gene	Start	Entry
HFSQLEGLPLGIQYF	TTC21B	426	Q7Z4L5
HGGVSSLLDFTLIYI	nan	31	Q0VG73
YAYPGVLLIGTDSHT	ACO2	181	Q99798
DSLYPHFTLLGQSLG	ALG11	141	Q2TAA5
DPNHTGGLYDFLLTA	ALS2CL	911	Q60I27
LSSYLHTAGLSFIPG	COL17A1	1201	Q9UMD9
VLGGQFHDYGLLTTP	PGM3	146	O95394
EYLQDLGLGAPSHSQ	ARHGEF18	31	Q6ZSZ5
SRQYGPGLLYLSSHG	CFAP43	636	Q8NDM7
TYGTGADLFLIHPST	CDHR1	511	Q96JP9
ADLFLIHPSTGLIYT	CDHR1	516	Q96JP9
LILGSGHYAAGLDLN	AREG	16	P15514
FEFLYNHGIGTLSSP	BUB1	86	O43683
HLLSCYDSGEPVFLG	B3GLCT	361	Q6Y288
LPIGYGAHIQFLNFS	CSMD1	2006	Q96PZ7
LGSYSGTTIPHLLNS	CSMD3	2006	Q7Z407
QYGHLLVGGRPTSAF	CSPG4	1986	Q6UVK1
STGLAGNLLGDLHYT	CHTF8	31	P0CG13
GNLLGDLHYTTEGIP	CHTF8	36	P0CG13
SPGLYGFLNVIVHSA	BCR	906	P11274
LNFYEGHITSLLGPN	ABCA12	1366	Q86UK0
LIAYGHLTGNAPDST	ARFGEF1	106	Q9Y6D6
LGLGFPHNFQETTYL	RASGRP1	536	O95267
IHGTFSLGPSIVYIE	ADGRV1	5216	Q8WXG9
SQIYGLIHGDLCFIP	ADGRV1	6041	Q8WXG9
GYLGGFLLVLHSQTD	COL4A4	1461	P53420
ALVLTSYGGHIGFLE	ABHD3	366	Q8WU67
ILLGHSLGGFLATSY	ABHD4	141	Q8TB40
DTLTIHGLPTEGYQA	C22orf31	201	O95567
DTFLGLPQYHGLQVA	AMN	276	Q9BXJ7
GHYPDFLAAGIILLA	SLC7A4	166	O43246
ALSGAPISFIHLLSY	CCKBR	366	P32239
PSYEAHLLLRGSAGT	DDN	201	O94850
TLTNILLSGVPTYGH	BICC1	526	Q9H694
PDLTRLYSGSLVHGL	ASTE1	566	Q2TB18
LGRAAQGSSPSHVLY	ADAMTS16	191	Q8TE57
LFLPAVSGLSHVDYA	ACAD11	436	Q709F0
LEALISGHYPTSLEG	POLL	211	Q9UGP5
LPGLFSYAQHIASID	MTCH2	51	Q9Y6C9
HLYGESALNGLPLDS	RAB19	186	A4D1S5
IFVGGLPYHTTDASL	RBM38	36	Q9H0Z9
AVTHGLRAYDGLSLP	HSPG2	21	P98160
LNLHTLLYLGGVEPS	HSPG2	4046	P98160
YLHDLSQSGTYPRGL	QRICH2	781	Q9H0J4
GAVYLFHGVLGPSIS	ITGAX	551	P20702
SGILPVYHSLFALAT	JAK3	61	P52333
YHVLQASEPGLFSLG	PCDHGB6	606	Q9Y5F9
ITNVLLPSGFSHYLG	LRRC9	1401	Q6ZRR7
LPSGFSHYLGSDVTL	LRRC9	1406	Q6ZRR7
YAHPLETLILGTGFF	MSMO1	186	Q15800
PYGDILLHTGDFTEL	MPPED2	76	Q15777
SQLTHGITELGPYTL	MUC16	13416	Q8WXI7
GQEPLSHGLLYALGL	ABCC10	316	Q5T3U5
GSLQDIYHVTGPLSE	MAP4K3	96	Q8IVH8
ASGLVPGLHFYTLNR	MTHFR	311	P42898
AFHGLTPGYLYNLTV	PTPRB	256	P23467
YGSAAQHLPYLTSLL	SLC46A1	306	Q96NT5
LHFLTPGVNNSGSYI	IL18RAP	111	O95256
GSYGLIAHAVLQLPT	OR52W1	221	Q6IF63
GDLSGHLLAYLSLSP	DOLPP1	26	Q86YN1
EALYRAGIHPLSLGS	NEIL2	236	Q969S2
LYVDTIGFLSQLPHG	GTPBP6	346	O43824
GTLAALYPVAFSSHL	MMS19	511	Q96T76
SLYDPGFLQQLHTVG	INPP4B	646	O15327
YLTGSFPSLHNLLEG	KIAA1109	2296	Q2LD37
LYHAATGSLPFIPFG	IKBKE	211	Q14164
GLASYLHGHEPSNLV	DDX60L	1421	Q5H9U9
TFLSLSGPHLGTLYN	FAM135A	1351	Q9P2D6
SGPHLGTLYNSSALV	FAM135A	1356	Q9P2D6
LAGAVGFFTHYLLPQ	PCNX3	1086	Q9H6A9
SLGLLLPGSHYLGRF	PCNX4	646	Q63HM2
IGAPYAVTAELLSHF	PCYT2	286	Q99447
QHLARDPTSGTLYLG	PLXNB1	36	O43157
VGQYLDSHPFLAFTL	LDAF1	41	Q96B96
FLLLEYASGLFAHPS	NUP85	401	Q9BW27
HSPLYFLLGNLSFLD	OR4L1	56	Q8NH43
SYHVLQASEPGLFSL	PCDHGB1	601	Q9Y5G3
YHVLQASEPGLFSLG	PCDHGB2	606	Q9Y5G2
LTLIGSPNFGYRSVH	PGS1	481	Q32NB8
HSYGGTLPSVLSQIE	LY75	981	O60449
PLSHNGVLTGYVLSY	L1CAM	941	P32004
NGPHVYQDLLLSLGT	IL7R	396	P16871
SYHVLQASEPGLFSL	PCDHGB5	601	Q9Y5G0
YHIVQASEPGLFSLG	PCDHGB3	606	Q9Y5G1
PATVDHLQGLYGLSA	OSR2	31	Q8N2R0
AANLTLGLYIHFGPR	SLC2A6	351	Q9UGQ3
GTASYHGFLPVLVRN	HUWE1	351	Q7Z6Z7
LSAYPHQLSFSEAGL	SLC24A3	316	Q9HC58
LVHYFGAELAASSLP	PTPRU	661	Q92729
SSSLTPIGHSFYNGL	PUM1	721	Q14671
GATHGLIFLPVLLSY	NPC1	1236	O15118
HTPIYLFLGSLAFAD	OR5AC1	56	P0C628
ASGSPHAVYFLLLLT	PRSS36	836	Q5K4E3
PYHADPSLVSFLTGL	TP73	486	O15350
LFRYDLEGGSSNHPL	DYNC2H1	2506	Q8NCM8
LEGGSSNHPLDYVLE	DYNC2H1	2511	Q8NCM8
GSFLYHLNEGEPLVA	ETFDH	306	Q16134
YSLAGRHGSTEPLVL	CRNKL1	31	Q9BZJ0
GLGFSLEYPTISLHA	CLNS1A	51	P54105
YLYGLHPNAEIGFLT	DNAH17	4151	Q9UFH2
LQDYGFHISESLPLT	FRMPD1	66	Q5SYB0
HLVGSALSDPYLSFA	CS	276	O75390
GPDGIQVSGYLHFLL	CYP27A1	301	Q02318
PAINYLLSHGTGNLV	AWAT1	161	Q58HT5
SYPFVLSANLHGGSL	CPD	661	O75976
LSANLHGGSLVVNYP	CPD	666	O75976
IGIPYSSQGHLQIFD	DNAAF9	161	Q5TEA3
YLLASSFLGLGLHPI	DEGS2	211	Q6QHC5
YLFPALLLHGLGEGS	APCDD1	11	Q8J025
PSYHFIGSLAVADLL	CNR1	151	P21554
PSQGLSFSYGDILHV	DLG3	521	Q92796
LYTLVSGSLPFDGHN	MARK4	246	Q96L34
GYELLQGHLPLKSFT	MASP2	331	O00187
ISDLHSGAGTLRPYL	LSMEM2	51	Q8N112
QLPHLGFYVANGSGL	ITIH6	1221	Q6UXX5
IISALLPAVAHGGNY	ITGA10	986	O75578
LPAVAHGGNYFLSLS	ITGA10	991	O75578
NQYSLTVGLDLGPHD	GBF1	1371	Q92538
GIALQHGSPYRDLFS	GRID1	771	Q9ULK0
GVQYPSSINLTLHLG	LAMC1	126	P11047
IHVLSAYASIGPLTG	CUL9	146	Q8IWT3
PSQGLSFKYGDILHV	DLG2	556	Q15700
HTFPAVLQSSGLYSL	IGHG1	51	P01857
HTFPAVLQSSGLYSL	IGHG2	51	P01859
HTFPAVLQSSGLYSL	IGHG3	51	P01860
HTFPAVLQSSGLYSL	IGHG4	51	P01861
LFYLPNGTVILHTGD	DCLRE1A	801	Q6PJP8
LYGLHPNAEIGFLTQ	DNAH9	4176	Q9NYC9
LSGPHLGTLYNNSTL	FAM135B	1246	Q49AJ0
GNSGHPLVLSYIDLS	HDAC6	1166	Q9UBN7
QILLALGHGGSAYSA	HELZ2	1686	Q9BYK8
RPFLAHSAGYILGSV	DUSP4	51	Q13115
GASYFRLGPHTILSL	SLC25A35	271	Q3KQZ1
VGYFGLSLDTPNLHG	SLC22A5	356	O76082
TLATGLYPESHGIVG	ENPP2	216	Q13822
TGGLYSHLPQSTEEL	INVS	841	Q9Y283
IHGEGSTFSTLYGLL	FAN1	831	Q9Y2M0
SVFYPGTLLETGHDI	VARS1	811	P26640
FGHSVVPLLDSYDLL	MEIOC	696	A2RUB1
NVPGSHLYASTGDLL	STARD13	461	Q9Y3M8
GAARAQYSLPGILHF	STRN	41	O43815
YPAGHSFILILGNSK	TAS2R3	276	Q9NYW6
LSHGGAPELLVGLSY	SYT16	501	Q17RD7
EGYLSHTGLAPFLLN	TCAF2	66	A6NFQ2
FDHDSLYLGASNSLP	PLEKHG4	1086	Q58EX7
GPLLEAYSSAAIFVH	GPAM	726	Q9HCL2
GSSLLHEAQFYGLTP	SHKBP1	91	Q8TBC3
GLIHYSFLNPGETIT	SETMAR	541	Q53H47
YGLLQVSEGLSFLHS	SCYL2	156	Q6P3W7
LTLGGDHTITYPILQ	AGMAT	156	Q9BSE5
TSHLLGDAGSPYLIG	SPNS2	466	Q8IVW8
PAADSRGHYQLLLSG	MYCBP2	56	O75592
SLGVGDTLYLVNGLH	PNKP	86	Q96T60
LGAYISFGVPSSHLL	SLC28A3	376	Q9HAS3
LYIGSTAGVAQLPLH	SEMA3A	501	Q14563
GLGPGHSYVSLFLAD	PRORP	21	O15091
PLGFYHGLSSTLLRE	SLC25A15	166	Q9Y619
HGLSSTLLREVPGYF	SLC25A15	171	Q9Y619
PLGFYHGLSSTLLQE	SLC25A2	166	Q9BXI2
HGLSSTLLQEVPGYF	SLC25A2	171	Q9BXI2
TPGGTTIYGLHALEQ	PYCR3	236	Q53H96
SEHLGADGGLYQIPL	NCKIPSD	151	Q9NZQ3
ASYGGSLLPEGHLNL	SLCO4A1	486	Q96BD0
DSYGLTPLYHTAIVG	SHANK2	261	Q9UPX8
EHPLYILYTSGTTGL	ACSS3	291	Q9H6R3
GSSYGDLLHNSIYPL	ARID5B	1151	Q14865
GGQLPFLLYGTEVHT	CLIC1	61	O00299
LFSSYRLPGHTQDTL	CHAT	276	P28329
LHGPLGLYLLSFISG	CLRN1	131	P58418
HLCPTLYESRFQLGG	C11orf68	261	Q9H3H3
PLLLFSSLQHGYSLA	TBC1D24	366	Q9ULP9
TYQSLYSGAPSHLGI	TBX10	326	O75333
GISGLAASYHLSRAP	PPOX	11	P50336
NRFLYVGGALHALPT	PPOX	96	P50336
SPLITLETQDGYFSH	XYLT1	126	Q86Y38
LGEYFLFTSHLDSLP	ZCWPW1	341	Q9H0M4
LTALYGPDFTQHLGK	TNFAIP8L2	156	Q6P589
PGLRHQLGAAFTLLY	GGCX	356	P38435
YLTVENGIAPNHGLT	RNPC3	136	Q96LT9
SLLQHSLYVGAPSGV	SEMA4G	486	Q9NTN9
LYLDEAHSIGALGPT	SPTLC2	341	O15270
HLPRFSISGTYNLED	SERPINA11	311	Q86U17
LLTGLTPGTHYQLDV	TIE1	606	P35590
HSVLNLLFLGYPFGV	TMEM39A	181	Q9NV64
SHLLGDAGSPYLIGL	SPNS1	426	Q9H2V7
YSSGGDLHLELPTGQ	TMEM131	246	Q92545
LGELHDFIPGTSGYL	TERB2	186	Q8NHR7
LDFYGIQPGSTVHVL	UBL7	76	Q96S82
TILPELGGYINESGH	XRN1	316	Q8IZH2
YLNGALLHEGPGSSL	SIGLEC1	546	Q9BZZ2
GPDVLVYSLDFGGHL	WDR6	36	Q9NNW5
ASYGLALLHPQGFEV	TMEM187	151	Q14656
LENYGHLVSLGLSIS	ZNF140	36	P52738
GAAGSSTLFLGPHLY	ZNRF3	726	Q9ULT6
HLLSTYYVPGSLLGA	ZNF74	591	Q16587
FPLASSLYGIQIADH	ZBTB2	126	Q8N680
QEDLLHGNPGSTYLA	ZC3HAV1	336	Q7Z2W4
DHGPSYLLRFLGQNL	PI15	111	O43692
HGYLSLLYDSPSGNL	PLEKHG1	806	Q9ULL1
ILAGIYINGHPTSNA	PLXDC1	441	Q8IUK5
LSSVHPVFGLYGSLF	SLC26A7	71	Q8TE54
QGHSVTYPLGTFILL	TGM7	126	Q96PF1
PGYTTLAGLDLSHNL	TSKU	81	Q8WUA8
GSLYHALLQPVVAGG	UPK3B	246	Q9BT76
LTLSLYDPHSSDLGG	TTLL10	401	Q6ZVT0
PSAFDVGYTLVHLAI	ZRANB1	306	Q9UGI0
LTSYGQLSNGEPHFL	YTHDF2	86	Q9Y5A9
DGSLLFEYLPRGAHS	ZBTB46	391	Q86UZ6
GLFLNSYTEIGTSHP	TRIO	361	O75962
PDSTQLILEHAGSYF	TRIO	1391	O75962
LGGPFHVIIITYASL	TRPV5	421	Q9NQA5
LTYFGVVHGPSAQLL	WDR54	31	Q9H977
LVSTANLIGPGHSFY	ZFHX3	351	Q15911
GQSPGAALHIYASVL	ZAN	296	Q9Y493